drugset / Trial / NCT01687777

Mensenchymal Stem Cell (MSC) Included in OrthADAPT Membrane for Rotator Cuff Tears Repair

NCT01687777 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Surgical reconstructive procedures for rotator cuff tears present a number of limitations. The few studies in which the repair integrity is evaluated, have shown the existence of a high rate of reruptures in spite of the fact that the functional results obtained short-term are satisfactory. Morphologic analysis from the sutures, after different follow-up periods, has not shown satisfactory results. Thus, the purpose of the current study was to test the hypotheses that mesenchymal stem cells (MSCs) included in a membrane into rotator cuff tears improves, the radiograms and the function compared to cell-free tendon defect treatment.

Timeline

Start
2010-05
Primary completion
2013-06
Completion
2013-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mesenchymal Stem Cells (MSCs) Cell therapy 2e+07 cells —

Indications

No indication recorded.